Speaker in Pharma Session 2 – Biosimilars – similar but different?
Monday, September 19, 2016 from 11.00 to 12.30
Bryan C. Zielinski is Vice President, Assistant General Counsel at Pfizer Inc. where he has been an attorney for over 20 years. He leads a team of Pfizer attorneys who are the lead IP attorneys for the small molecule therapeutics portion of Pfizer’s Global Innovation Pharma Business Unit and advises senior management regarding IP matters associated with this Business Unit’s clinical candidate and product portfolio.
Bryan also represents Pfizer on the IP committees of various policy-focused industry organizations, including BIO and PhRMA. Prior to joining Pfizer in 1994, Bryan was an associate at the New York IP firm Davis, Hoxie, Faithfull and Hapgood which he joined in 1989 and where he focused primarily on patent litigation.